3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary–adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity

We have previously shown that ± 3,4-methylenedioxymethamphetamine (MDMA) treatment from P11 to P20 in rats produces deficits in cognitive ability when these animals are tested in adulthood. The purpose of this experiment was to explore the neuroendocrine and neurochemical changes produced by MDMA tr...

Full description

Saved in:
Bibliographic Details
Main Authors: Williams, Michael T., Schaefer, Tori L., Ehrman, Lisa A., Able, Jessica A., Gudelsky, Gary A., Sah, Renu, Vorhees, Charles V.
Format: Artigo
Language:Inglês
Published: 2005
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2888318/
https://ncbi.nlm.nih.gov/pubmed/15781051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.brainres.2005.01.045
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items